PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $248 | -99.5% | 6,434 | +658.7% | 0.00% | – |
| Q4 2021 | $51,000 | -82.1% | 848 | -83.1% | 0.00% | -100.0% |
| Q3 2021 | $285,000 | -67.5% | 5,005 | -65.3% | 0.00% | -50.0% |
| Q2 2021 | $876,000 | -74.6% | 14,418 | -70.6% | 0.00% | -75.0% |
| Q1 2021 | $3,443,000 | +1103.8% | 48,999 | +924.0% | 0.01% | – |
| Q4 2020 | $286,000 | -60.3% | 4,785 | -60.1% | 0.00% | -100.0% |
| Q3 2020 | $721,000 | +253.4% | 12,000 | +96.9% | 0.00% | +100.0% |
| Q1 2020 | $204,000 | -79.8% | 6,095 | -72.7% | 0.00% | -75.0% |
| Q4 2019 | $1,012,000 | +20.5% | 22,342 | -1.9% | 0.00% | +33.3% |
| Q3 2019 | $840,000 | -78.8% | 22,775 | -75.5% | 0.00% | -66.7% |
| Q2 2019 | $3,962,000 | +128.0% | 93,060 | +100.5% | 0.01% | +28.6% |
| Q1 2019 | $1,738,000 | +20.4% | 46,411 | +38.2% | 0.01% | +40.0% |
| Q4 2018 | $1,443,000 | +201.9% | 33,573 | +235.7% | 0.01% | +150.0% |
| Q3 2018 | $478,000 | +62.0% | 10,000 | +223.0% | 0.00% | +100.0% |
| Q3 2014 | $295,000 | +13.9% | 3,096 | +7.2% | 0.00% | – |
| Q2 2014 | $259,000 | -17.3% | 2,888 | -34.6% | 0.00% | – |
| Q1 2014 | $313,000 | -22.1% | 4,419 | -80.9% | 0.00% | -100.0% |
| Q4 2012 | $402,000 | – | 23,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |